Department of Oncology, Beijing Chaoyang Hospital, Capital University of Medical Science, Beijing, China.
Radiol Oncol. 2011 Dec;45(4):273-8. doi: 10.2478/v10019-011-0029-0. Epub 2011 Sep 22.
The aim of the study was to compare the survival of patients receiving laparoscopic vs. open radical resection for stage II colon cancer.
Two hundred and twenty patients with stage II colon cancer were enrolled from Beijing Chaoyang Hospital of Capital Medical University from January 2000 to December 2009, including 61 patients in the laparoscopic radical resection group and 159 patients in the open radical resection group. The survival data in both groups were compared using the log rank test based on Kaplan-Meier survival curves.
There was no statistically significant difference in the 3-year survival (88.5% vs. 80.5%; X(2)=1.98, P=0.159) and the 5-year survival (81.9% vs. 69.2%; X(2)=1.98, P=0.159) between both groups. However, statistically significant difference was found in median overall survival (mOS), which was 102.6 (95% CI: 76.8-122.7) months in the laparoscopic group and 90.0 (95% CI: 70.4-109.6) months in the open radical resection group (X(2)=4.183, P=0.041). mOS was 96 (95% CI: 68.6-111.4) months and 92.6 (95% CI: 56.8-107.2) months in those with and without postoperative chemotherapy, respectively (X(2)=6.389, P=0.011). For patients older than 75 years the mOS was 90.0 (95% CI: 25.3-105.0) months and 83.4 (95% CI: 13.1-96.9) months in the laparoscopic and open group, respectively. The difference between the both groups was statistically significant (X(2)=6.191, P=0.013).
The mOS of patients receiving laparoscopic radical resection was better than open radical resection for stage II colon cancer, especially for patients over 75 years old.
本研究旨在比较接受腹腔镜与开腹根治性切除术的 II 期结肠癌患者的生存情况。
本研究共纳入 2000 年 1 月至 2009 年 12 月首都医科大学附属北京朝阳医院收治的 220 例 II 期结肠癌患者,其中腹腔镜根治性切除术组 61 例,开腹根治性切除术组 159 例。采用基于 Kaplan-Meier 生存曲线的对数秩检验比较两组患者的生存数据。
两组患者的 3 年生存率(88.5%比 80.5%;X(2)=1.98,P=0.159)和 5 年生存率(81.9%比 69.2%;X(2)=1.98,P=0.159)差异无统计学意义。然而,两组患者的中位总生存期(mOS)差异有统计学意义,腹腔镜组 mOS 为 102.6(95%CI:76.8-122.7)个月,开腹根治性切除术组为 90.0(95%CI:70.4-109.6)个月(X(2)=4.183,P=0.041)。术后未接受化疗患者的 mOS 为 96(95%CI:68.6-111.4)个月,接受化疗患者的 mOS 为 92.6(95%CI:56.8-107.2)个月(X(2)=6.389,P=0.011)。对于年龄大于 75 岁的患者,腹腔镜组 mOS 为 90.0(95%CI:25.3-105.0)个月,开腹组为 83.4(95%CI:13.1-96.9)个月,两组间差异有统计学意义(X(2)=6.191,P=0.013)。
对于 II 期结肠癌患者,腹腔镜根治性切除术的 mOS 优于开腹根治性切除术,特别是对于年龄大于 75 岁的患者。